2023
July 2023
3BIGS Collaborates with Amazon Web Services in healthcare solution marketing
May 2023
3BIGS signs Memorandum of Understanding (MOU) with Bangalore Castro Center (BGC)
February 2023
3Bigs Opens Bio Big Data Center 2 in Hyderabad, India
January 2023
Hancom Medical Solutions invests in 3 Bigs
2022
November 2022
3BIGS signed a memorandum of understanding (MOU) with Seoul National University Graduate School of Public Health for the research and development of healthcare big data
August 2022
- 3BIGS selected as the leading organization for the multidrug-resistant tuberculosis drug candidate prediction research project by the Korea Centers for Disease Control and Prevention (KCDC)
- 3BIGS chosen by Amazon Web Services ( AWS ) as the only medical data partner in Korea
June 2022
- Signed a Memorandum of Understanding (MOU) with Korea Bio-Self – MOU for the development of mRNA vaccines
- 3BIGS Selected for ‘Advanced Cancer Patient Multi-Dimensional Data Utilization System’ project by the National Cancer Center
April 2022
Signed a Memorandum of Understanding (MOU) with Hancom Carelink – Development of health checkup service using gut microbiome analysis
February 2022
Signed a Memorandum of Understanding (MOU) with Pusan National University AI Graduate School – Bio big data and AI-based infectious disease diagnostic markers and treatment development
2021
December 2021
Memorandum of Understanding (MOU) with Cosmax Pharma – business agreement ceremony for bio big data and AI-based new drug development
November 2021
- 3BIGS registers two patents related to the treatment of inflammatory skin and oral diseases with the Korean Intellectual Property Office (KR)
- Signed a memorandum of understanding (MOU) with Chong Kun Dang Bio – business agreement for development of bio big data and AI-based microbiome treatment
- Signed a memorandum of understanding (MOU) with AWS Korea – AWS utilization related to integrated linkage of biohealth information and disease linkage analysis
- Relocation of 3BIGS office expansion (Dongtan Geumgang Penterium IX Tower)
October 2021
3BIGS signs Memorandum of Understanding (MOU) with AI Insight – Business Agreement for Bio Health Platform Business
September 2021
Signed a memorandum of understanding (MOU) with Pusan National University Hospital – development of smart diagnosis and treatment
July 2021
- 3BIGS participates The global startup fair ‘NextRise 2021, Seoul’
- 3BIGS Participates in the 19th Interbiz Bio Partnering & Investment Forum 2021
June 2021
Expansion of Seoul AI / IT Lab (Songpa-gu, Seoul)
April 2021
- National Institute of Marine Science and Technology Promotion, establishment and operation of marine biological resource material information system selected as a national project
- National Institute of Marine Science and Technology Promotion, big data-based marine virus control and development of marine biotics selected as a national project
- Safety Evaluation Research Institute, selection of toxicity information and text mining analysis tasks for liver toxic compounds
- Selected as a project to advance the multi-dimensional data utilization system for cancer patients by the National Cancer Center
February 2021
Signed a memorandum of understanding (MOU) with Ames Bio – for joint research on new drug development using AI
January 2021
Signed a memorandum of understanding (MOU) with TS Trillion – for the Utilization of AI Bio Big Data
2020
December 2020
- Three Bigs participates in the Korea Bio Association BIO-BLAZE event
- Signed Memorandum of Understanding (MOU) with CURADIGM – to develop new drugs through digitization and knowledge of bio data necessary for new drug development
November 2020
Signed a memorandum of understanding(MOU) with Seoul National University Graduate School of Dentistry – bio big data platform establishment and joint research on disease diagnosis technology
October 2020
3BIGS selected for ‘in vitro diagnostic medical device development project using artificial intelligence’ hosted by the Korea Health Industry Development Institute
September 2020
Invited to Women’s Disease and Microbiome Symposium hosted by Ewha Womans University Medical Center
August 2020
Signed a memorandum of understanding (MOU) with the Gyeonggi-do Global Pharmaceutical Material Development Research Center – Joint research on new drug candidate substance derivation structure design and synthesis technology
July 2020
Signed a memorandum of understanding (MOU) with DNA Link – AI New Drug Development Joint Research
June 2020
Signed a memorandum of understanding (MOU) with the Seoul National University Agricultural and Life Science Joint Research Institute – cooperation in discovering diagnostic markers and useful new drugs
May 2020
Signed a memorandum of understanding (MOU) with the College of Pharmacy, Sungkyunkwan University – AI-based new drug development research cooperation / education
April 2020
Signed Memorandum of Understanding (MOU) with Medilita – AI-based new drug development project
February 2020
Selected as participating companies in Phar East 2020, Singapore (8 Korean companies / Korea Health Industry Development Institute)
2019
December 2019
Signed a memorandum of understanding with (MOU) Ewha Womans University Medical Center
October 2019
- 3BIGS conducted “Metagenome Analysis Education” at the Korea Bio Association
- Participated in the 2019 Korean Society of Molecular and Cellular Biology
September 2019
Selected as a national project for start-up growth technology development project by the Ministry of Small and Medium Business Ventures
July 2019
Korea Health Industry Development Institute, AI New Drug Development Support Pilot Project Selection (Korea Pharmaceutical Bio Association)
June 2019
- Signed Memorandum of Understanding (MOU) with Ami Cosmetics
- 3BIGS held the 1st Korea Microbiome Society training workshop “Microbiome Analysis Theory and Practical Training” at Yonsei University College of Medicine
May 2019
Selected for advanced technology and product confirmation by Ministry of Trade, Industry and Energy
April 2019
- Signed Memorandum of Understanding (MOU) with Asia Seed – to develop new functional vegetable varieties through the use of big data analysis
- Invitational Presentation at the opening ceremony of Artificial Intelligence New Drug Development Support Centre jointly established by the Korea Pharmaceutical Bio Association and the Korea Health Industry Development Institute, Minister of Health and Welfare
March 2019
Relocation of 3BIGS headquarters office expansion – Gwanggyo Business Center (Suwon)
February 2019
Signed Memorandum of Understanding (MOU) with Holocene Ecology Conservation Research Institute
2018
December 2018
3BIGS participates in international symposium hosted by National University of Incheon to establish an R&D education research infrastructure and agenda for global health and quarantine
November 2018
- 3BIGS Participates in TBC / BIOINFO, The 8th Annual Translational Bioinformatics Conference held in Gangnam
- Selected as First Penguin Company by Korea Credit Guarantee Fund
October 2018
3BIGS
August 2018
Korea Centers for Disease Control and Prevention, selected for ‘Planning Research for Infectious Pathogen Integrated Gene Information Collection and Analysis Management System
July 2018
Ministry of Science and ICT, Ministry of Trade, Industry and Energy, National Police Agency joint national project execution agency selection
May 2018
3BIGS OMICSCORE PVT. LTD. Established Indian corporation
April 2018
Established 3 Bigs Co., Ltd. (conversion to a corporation)
January 2018
- 3BIGS venture business certification
- Selected as the host organization for the post-genome multi-departmental genome project (National Institute of Agricultural Sciences)
2017
November 2017
Recognized as an affiliated research institute (No. 2017115487)
October 2017
Signed a domestic sales agent contract with geneXplain in Germany
September 2017
Signed a domestic sales agency contract with Nebion, Switzerland
August 2017
Signed a domestic sales agency contract with India’s Excelra
July 2017
Established 3BIGS (individual)